EAC (n = 89) | GAC (n = 371) | ||
---|---|---|---|
n (%) | n (%) | ||
Sex | |||
Male | 77 (86.5) | 242 (65.2) | |
Female | 12 (13.5) | 129 (34.8) | |
Median age (range) | 69 years (28–86 years) | 67 years (30–90 years) | |
pT | |||
pTx | 15 (16.8) | 4 (1.1) | |
pT0 | 1 (1.1) | 0 (0.0) | |
pT1 | 23 (25.8) | 16 (4.3) | |
pT2 | 11 (12.3) | 80 (21.6) | |
pT3 | 38 (42.7) | 174 (46.9) | |
pT4 | 1 (1.1) | 97 (26.1) | |
pN | |||
pNx | 16 (18.0) | 11 (3.0) | |
pN0 | 22 (24.7) | 115 (31.0) | |
pN1 + | 51 (57.3) | 245 (66.0) | |
M | |||
Mx | 32 (36.0) | 5 (1.3) | |
M0 | 52 (58.4) | 347 (93.5) | |
M1 | 5 (5.6) | 19 (5.1) | |
TCGA molecular subtypea | |||
NA | – | 131 (35.3) | |
EBV | – | 24 (6.5) | |
MSI-high | – | 48 (12.9) | |
GS | – | 48 (12.9) | |
CIN | – | 120 (32.3) | |
CLDN6 expressionb | |||
> Best cutoff | 14 (15.7) | 68 (18.3) | |
< Best cutoff | 75 (84.3) | 303 (81.7) | |
Her2/ERBB status | |||
Amplified | 47 (5.9) | ||
Not amplified | 518 (64.5) | ||
NA | 238 (29.6) |